Biosimilars LatAm – Brazil 2024
The 2024 edition in Brazil aims to delve into the hurdles of producing monoclonal antibodies locally, discuss effective strategies for navigating the complex landscape of biosimilar licensing in Brazil, and explore the economic implications of biosimilar usage, focusing on cost savings, accessibility, and the evolving market dynamics in the country.
Plan Your 1-to-1 Meetings with JackLeckerman App
1. JackLeckerman App: Login & Meeting Notifications
Download the JackLeckerman App and sign up.
Check your email for the login details, or use the “Forgot Password” option to retrieve them.
You will receive meeting reminders on your mobile over the 2 days.
These reminders will include meeting requests, meeting confirmations, and messages from other attendees and the coordinator.
2. Attendee list to Plan Your Meetings
Browse the attendee list and select someone for a 10-minute 1-to-1 Meeting request.
Meeting requests close one hour before each Networking session in the program.
3. Managing Meeting Requests, Your Meetings Schedule
Accept or decline meeting requests through the “Meetings” button.
Check your scheduled meetings for the upcoming networking break.
4. Meeting Point Location in the Coffee Break Area
Go to the coffee break area and find the table number to meet your colleague
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Program at a Glance
Biosimilar Regulatory Updates
Invited: ANVISA
The Benefits of Mexico's New Regulatory Certainty Strategy
Brazil's Industry Contributions to CEPAL
Challenges in Local Production of Monoclonal Antibodies
Navigating the Landscape of Biosimilar Licensing: Strategies for Successful Market Entry in Brazil
Economic Impacts of Biosimilar Administration in Brazil: Cost Savings, Access, and Market Dynamics
From Brazil to Europe: Strengthening a Transcontinental Bond
Invited: INFARMED & AEMPS & MHRA
Harmonization and Reliance Efforts in South America
Invited: Regulatory Agencies of Reference
Full Programme in the PDF Agenda
Download Agenda
Speaker Board in 2023
Ana María Agueda Chura Tito
Pharmaceutical Chemist
Leila Almeida
Sales Manager
Rafael Munerato de Almeida
Founder
Rafael Costa
Strategy and Business Executive Director
Hugo Garcia Tonioli Defendi
Biopharmaceutical Program Manager
Ricardo Garcia
Director
Ana Luiza Vivan
Strategic Partnership Manager
Ana Luisa Lampert Cadore
Technical Application Specialist – Single-use Technologies
Priscila Torres
Advocacy and Social Responsibility Coordinator
Fernando César Barbosa
Founder & CEO
Fernando Da Costa Ribeiro
Third Parties Service Manager
Fabricio Carneiro de Oliveira
General Manager
Ramses Gamboa
Business Development Manager
Gustavo Mendes Lima Santos
Director of Regulatory, Quality and Clinical Trials
Marcos Roman Calgaro
LatAm Bioproduction Director
Nestor Lago
Medical Director
Sonia Mayra Pérez Tapia
Executive Director
Thiago Mares Guia
Executive Vice President